Fatigued muscles in COPD but no finishing line in sight Gosker H. R., Schols A. M. W. J. Eur Respir J 2008; 31: 693-694 | |
Reversing concepts on COPD irreversibility Soriano J. B., Mannino D. M. Eur Respir J 2008; 31: 695-696 | |
Hypoxia-driven mechanisms in lung biology and disease: a new review series of the ERS Lung Science Conference Weissmann N. Eur Respir J 2008; 31: 697-698 | |
Regulating spoons Bush A. Eur Respir J 2008; 31: 699-700 | |
Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler ECG study Papadopoulos C. E., Pitsiou G., Karamitsos T. D., Karvounis H. I., Kontakiotis T., Giannakoulas G., Efthimiadis G. K., Argyropoulou P., Parharidis G. E., Bouros D. Eur Respir J 2008; 31: 701-706 | |
Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection Blondeau K., Mertens V., Vanaudenaerde B. A., Verleden G. M., Van Raemdonck D. E., Sifrim D., Dupont L. J. Eur Respir J 2008; 31: 707-713 | |
Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor Uddin M., Seumois G., Lau L. C., Rytila P., Davies D. E., Djukanovic R. Eur Respir J 2008; 31: 714-724 | |
Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms Slevogt H., Maqami L., Vardarowa K., Beermann W., Hocke A. C., Eitel J., Schmeck B., Weimann A., Opitz B., Hippenstiel S., Suttorp N., N'Guessan P. D. Eur Respir J 2008; 31: 725-735 | |
Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension Suntharalingam J., Goldsmith K., van Marion V., Long L., Treacy C. M., Dudbridge F., Toshner M. R., Pepke-Zaba J., Eikenboom J. C. J., Morrell N. W. Eur Respir J 2008; 31: 736-741 | |
Bronchodilator responsiveness in patients with COPD Tashkin D. P., Celli B., Decramer M., Liu D., Burkhart D., Cassino C., Kesten S. Eur Respir J 2008; 31: 742-750 | |
The plasma ammonia response to cycle exercise in COPD Calvert L. D., Singh S. J., Greenhaff P. L., Morgan M. D., Steiner M. C. Eur Respir J 2008; 31: 751-758 | |
Sildenafil treatment in COPD does not affect stroke volume or exercise capacity Rietema H., Holverda S., Bogaard H. J., Marcus J. T., Smit H. J., Westerhof N., Postmus P. E., Boonstra A., Vonk-Noordegraaf A. Eur Respir J 2008; 31: 759-764 | |
Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis Daviskas E., Anderson S. D., Eberl S., Young I. H. Eur Respir J 2008; 31: 765-772 | |
Mast cell-derived tumour necrosis factor is essential for allergic airway disease Reuter S., Heinz A., Sieren M., Wiewrodt R., Gelfand E. W., Stassen M., Buhl R., Taube C. Eur Respir J 2008; 31: 773-782 | |
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation Suzaki Y., Hamada K., Nomi T., Ito T., Sho M., Kai Y., Nakajima Y., Kimura H. Eur Respir J 2008; 31: 783-789 | |
Effectiveness of pharmacist intervention for asthma control improvement Mehuys E., Van Bortel L., De Bolle L., Van Tongelen I., Annemans L., Remon J. P., Brusselle G. Eur Respir J 2008; 31: 790-799 | |
Initiating oral breathing in response to nasal loading: asthmatics versus healthy subjects Hallani M., Wheatley J. R., Amis T. C. Eur Respir J 2008; 31: 800-806 | |
Respiratory effects of occupational exposures in a milk powder factory Sripaiboonkij P., Phanprasit W., Jaakkola M. S. Eur Respir J 2008; 31: 807-814 | |
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients Grasemann C., Ratjen F., Schnabel D., Reutershahn E., Vester U., Grasemann H. Eur Respir J 2008; 31: 815-821 | |
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Schelstraete P., Van daele S., De Boeck K., Proesmans M., Lebecque P., Leclercq-Foucart J., Malfroot A., Vaneechoutte M., De Baets F. Eur Respir J 2008; 31: 822-829 | |
Impact of a controlled heated breathing tube humidifier on sleep quality during CPAP therapy in a cool sleeping environment Nilius G., Domanski U., Franke K-J., Ruhle K-H. Eur Respir J 2008; 31: 830-836 | |
Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax Rena O., Massera F., Papalia E., Della Pona C., Robustellini M., Casadio C. Eur Respir J 2008; 31: 837-841 | |
Indeterminate test results of T-SPOTTM.TB performed under routine field conditions Beffa P., Zellweger A., Janssens J-P., Wrighton-Smith P., Zellweger J-P. Eur Respir J 2008; 31: 842-846 | |
Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism Jimenez D., Diaz G., Molina J., Marti D., Del Rey J., Garcia-Rull S., Escobar C., Vidal R., Sueiro A., Yusen R. D. Eur Respir J 2008; 31: 847-853 | |
Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis Moro-Sibilot D., Lantuejoul S., Diab S., Moulai N., Aubert A., Timsit J. F., Brambilla C., Brichon P. Y., Brambilla E. Eur Respir J 2008; 31: 854-859 | |
Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years Kuster S. P., Kuster D., Schindler C., Rochat M. K., Braun J., Held L., Brandli O. Eur Respir J 2008; 31: 860-868 | |
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) Vestbo J., Anderson W., Coxson H. O., Crim C., Dawber F., Edwards L., Hagan G., Knobil K., Lomas D. A., MacNee W., Silverman E. K., Tal-Singer R., on behalf of the ECLIPSE investigators Eur Respir J 2008; 31: 869-873 | |
Noninvasive positive pressure ventilation in the acute care setting: where are we? Ambrosino N., Vagheggini G. Eur Respir J 2008; 31: 874-886 | |
The biology of oxygen Wagner P. D. Eur Respir J 2008; 31: 887-890 | |
Prostacyclin therapies for the treatment of pulmonary arterial hypertension Gomberg-Maitland M., Olschewski H. Eur Respir J 2008; 31: 891-901 | |
Optimisation of bronchial brachytherapy catheter placement with a modified airway stent Kennedy M. P., Jimenez C. A., Chang J., Fossella F., Eapen G. A., Morice R. C. Eur Respir J 2008; 31: 902-903 | |
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? Migliori G. B., Lange C., Girardi E., Centis R., Besozzi G., Kliiman K., Codecasa L. R., Spanevello A., Cirillo D. M., the SMIRA/TBNET Study Group Eur Respir J 2008; 31: 904-905 | |
Concomitant use of β-blockers and β2-agonists Ling Y., Saleem W., Shee C. D. Eur Respir J 2008; 31: 905-906 | |
Meta-analysis may not be practicable for guiding antibiotic therapy Chang K. C., Leung C. C. Eur Respir J 2008; 31: 906-907 | |
From the authors Siempos I. I., Dimopoulos G., Falagas M. E. Eur Respir J 2008; 31: 907-908 | |
Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA? Laoudi Y., Paolini J-B., Grimfed A., Just J. Eur Respir J 2008; 31: 908-909 | |
Elevated levels of exhaled nitric oxide in recurrent tonsillitis Kasperska-Zajac A., Brzoza Z., Czecior E., Rogala B., Polok A., Namyslowski G. Eur Respir J 2008; 31: 909-910 | |
"SMOKING IS ASSOCIATED WITH AN AGE-RELATED DECLINE IN EXHALED NITRIC OXIDE". J.S. SUNDY, D.W. HAUSWIRTH, S. MERVIN-BLAKE, C.A. FERNANDEZ, K.B. PATCH, K.M. ALEXANDER, S. ALLGOOD, P.D. MCNAIR AND M.C. LEVESQUE. EUR RESPIR J 2007; 30: 1074-1081.
Eur Respir J 2008; 31: 911 | |
"ENVIRONMENTAL TEMPERATURE AND RELATIVE HUMIDITY INFLUENCE EXHALED BREATH CONDENSATE PH". T. KULLMANN, I. BARTA, B. ANTUS, M. VALYON AND I. HORVATH. EUR RESPIR J 2008; 31: 474-475.
Eur Respir J 2008; 31: 912 | |
"PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH FENFLURAMINE EXPOSURE: REPORT OF 109 CASES". R. SOUZA, M. HUMBERT, B. SZTRYMF, X. JAIS, A. YAICI, J. LE PAVEC, F. PARENT, P. HERVE, F. SOUBRIER, O. SITBON AND G. SIMONNEAU. EUR RESPIR J 2008; 31: 343-348.
Eur Respir J 2008; 31: 912 | |